Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;10(4):1878-1889.
doi: 10.21037/tau-20-1039.

Urinary extracellular vesicles: a rising star in bladder cancer management

Fumihiko Urabe  1   2 , Takahiro Kimura  1 , Kagenori Ito  1   2 , Yusuke Yamamoto  2 , Shunsuke Tsuzuki  1 , Jun Miki  1   3 , Takahiro Ochiya  4 , Shin Egawa  1
Affiliations
Review

Urinary extracellular vesicles: a rising star in bladder cancer management

Fumihiko Urabe et al. Transl Androl Urol. 2021 Apr.

Abstract

Clinically, the detection of bladder cancer (BCa) typically requires cystoscopy, which is potentially harmful and sometimes accompanied by adverse effects. Thus, new biomarkers are desirable for improving the management of BCa. Recently, "liquid biopsy" has received enormous attentions and has been extensively studied due to its promising clinical implication for precise medicine. Especially, extracellular vesicles (EVs) have attracted strong interest as a potential source of biomarkers. EVs have been reported to be found in almost all types of body fluids and are easy to collect. In addition, EVs tightly reflect the current state of the disease by inheriting specific biomolecules from their parental cells. Urinary EVs have gained great scientific interest in the field of BCa biomarker research since urine is in direct contact with BCa and can contain large amounts of EVs from the tumour microenvironment. To date, various kinds of biomolecules, including noncoding RNAs, mRNAs, and proteins, have been investigated as biomarkers in urinary EVs. In this narrative review, we summarize the recent advances regarding urinary EVs as non-invasive biomarkers in patients with BCa. The current hurdles in the clinical implications of EV-based liquid biopsy and the potential applications of EV research are also discussed.

Keywords: Extracellular vesicles (EVs); biomarker; bladder cancer (BCa); exosome.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/tau-20-1039). The series “Urinary Biomarkers of Urothelial Malignancies” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
Clinical application of extracellular vesicles (EVs) in bladder cancer management. Urinary EVs are likely to be clinically useful biomarkers for bladder cancer. EV-associated biomolecules can be examined using several modalities, including real-time PCR, western blotting, and ExoScreen assays and microfluidic devices. Three therapeutic applications have been proposed: 1. inhibition of EV secretion, 2. elimination of circulating EVs, and 3. disruption of EV absorption. These EV-targeted strategies may add additional value to existing therapeutic methods.
See this image and copyright information in PMC

References

    1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424. 10.3322/caac.21492 - DOI - PubMed
    1. Matsuda T, Okuyama A. Incidence rate for bladder cancer in Japanese in Japan and in the United States from the Cancer Incidence in Five Continents. Jpn J Clin Oncol 2017;47:284-5. 10.1093/jjco/hyx017 - DOI - PubMed
    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7-30. 10.3322/caac.21590 - DOI - PubMed
    1. Yafi FA, Brimo F, Steinberg J, et al. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol 2015;33:66.e25-31. 10.1016/j.urolonc.2014.06.008 - DOI - PubMed
    1. Têtu B. Diagnosis of urothelial carcinoma from urine. Mod Pathol 2009;22 Suppl 2:S53-9. 10.1038/modpathol.2008.193 - DOI - PubMed